MedTrace Logo

Evaluation of Green Tea as Antioxidant Agent in Management of Oral Lichen Planus

NCT02329600 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2016-11-15

Study results available
· View outcomes & findings →

Summary

The study included forty individuals divided into 3 groups. 10 control subjects, 15 oral lichen planus (OLP) patients who were treated with topical corticosteroids and 15 oral lichen planus (OLP) patients who were treated with topical corticosteroids and green tea tablets.

Conditions

  • Oral Lichen Planus

Interventions

DRUG

green tea tablets (Green tea extract 5:1) 200 mg

Green tea is a product made from the Camellia sinensis plant. The fresh leaves are used to make medicine. the green tea extract is presented in a form of tablets 200 mg and is taken orally.

DRUG

Triamcinolone Acetonide

topical corticosteroids (Kenalog in orabase: Bristol-Myers, Squibb, Spain) applied topically 4 times a day i.e. following each meal and at bed time for one month

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Noha Ghallab, M.D. · Associate Professor of periodontology and Oral Medicine faulty of oral and dental medicine Cairo Unv.

  • Enji Ahmed, M.D. · Lecturer of periodontology and Oral Medicine faulty of oral and dental medicine Cairo Unv.

  • Ghada Nabil, B.D.S · Instructor of periodontology and Oral Medicine faulty of oral and dental medicine Cairo Unv.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
68 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2014-08-31
Completion
2014-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02329600 on ClinicalTrials.gov